Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab

Rheumatology (Oxford). 2002 Feb;41(2):234-5. doi: 10.1093/rheumatology/41.2.234.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications*
  • Female
  • Humans
  • Infliximab
  • Mononeuropathies / etiology
  • Mononeuropathies / therapy*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab